Trama
Podcast by Cytokine Signalling Forum
Episodi
-
Rheumatology Author Dr Kerschbaumer: JAKinibs
29/12/2020 Durata: 22minDr Andreas Kerschbaumer from Vienna University. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Dr Andreas Kerschbaumer discusses his systematic review paper on “Points to Consider for the Treatment of Immune Mediated Inflammatory Diseases with Janus Kinase Inhibitors
-
Rheumatology Author Roy Fleischmann: Switching Between UPA and ADA
29/12/2020 Durata: 20minProfessor Roy Fleischmann, from the University of Texas Southwestern Medical Centre in Dallas, discusses data from the SELECT-COMPARE trial, where patients with RA were switched between upadacitinib and adalimumab in cases of insufficient response.
-
Rheumatology Author Prof Kevin Winthrop: Tofacitinib
22/12/2020 Durata: 21minProf Kevin Winthrop from OHSU. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Kevin Winthrop discusses aged based incidence of infections with tofacitinib
-
Discussing Rheumatology: JAK Inhibitors
22/12/2020 Durata: 20minProf Iain McInnes discusses JAK inhibitors. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com.
-
Perspectives in Inflammation - Professor Emery
09/12/2020 Durata: 22minPast President of EULAR and Carol Nachman Prize winner. In this podcast, Professor Paul Emery discusses his work in managing early RA and the growth of his unit at Leeds into a world leading centre for rheumatology research alongside Professor Michael Weinblatt. Perspectives in Inflammation is a series of in-depth interviews revealing what attracted world leading experts to the field of inflammation, their current research interests, and views on the latest developments in inflammation.
-
Insights at ACR 2020: Highlights from ACR 2020
30/11/2020 Durata: 10minGain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes a preview of an upcoming Highlights from ACR 2020 course from Professors Kevin Winthrop and Leonard Calabrese, available soon on the CSF website.
-
Rheumatology Author Prof Stanley Cohen: Upadacitinib
25/11/2020 Durata: 21minProf Stanley Cohen - University of Texas. Join Prof Peter Nash as he interviews notable figures in rheumatology. In this edition Prof Stanley Cohen discusses safety profile of upadacitinib
-
Discussing Rheumatology: Upadacitinib Safety
25/11/2020 Durata: 07minProf Iain McInnes discusses upadacitinib safety. Keep-up to date with the latest in arthritis and cytokine signalling with Prof Iain McInnes. Everything discussed is available in a more detailed slide format in the publications section at cytokinesignalling.com
-
Insights at ACR 2020: Efficacy And Safety Of JAK Inhibitors
23/11/2020 Durata: 31minGain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great efficacy and safety data on JAK inhibitors from Professors Kevin Winthrop, Stanely Cohen, Ernest Choy and Rene Westhovens.
-
Insights at ACR 2020: New Developments in Cytokine Signalling
23/11/2020 Durata: 26minGain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great new developments in cytokine signalling abstracts from Professors Iain McInnes, Xenfon Baraliakos and Maya Buch.
-
Insights at ACR 2020: Bone And Patient Outcomes With RA
19/11/2020 Durata: 19minGain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great bone and patient outcomes abstracts from Professors Rieke Alten, Vibeke Strand and Zoltan Szekanecz.
-
Insights at ACR 2020: Vaccinations and JAK Inhibitors
19/11/2020 Durata: 24minGain insight into the latest research presented at ACR 2020. Experts review their congress posters and presentations on cytokine signalling and JAK inhibitors. This edition includes some great vaccinations and JAK inhibitors abstracts from Professor Kevin Winthrop and Dr Rodriguez-Garcia.
-
Rheumatology Author Gustavo Citera: Interstitial Lung Disease
18/11/2020 Durata: 14minDr Gustavo Citera, Head of Rheumatology at the Institute of Psychophysical Rehabilitation, Buenos Aires, Argentina. Join Professor Peter Nash as he interviews authors of recent notable papers in rheumatology. In this edition, Dr Gustavo Citera discusses how JAK inhibition could be associated with interstitial lung disease events
-
Insights at ACR 2020: Day 4 RA Highlights
09/11/2020 Durata: 11minProf Leonard Calabrese presents the Day 4 highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 4 Beyond RA Highlights
09/11/2020 Durata: 08minProf Leaonard Calabrese presents Day 4 highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 3 RA Highlights
08/11/2020 Durata: 09minProf Christopher Ritchlin presents Day 3 highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 3 Beyond RA Highlights
08/11/2020 Durata: 05minProf Christopher Ritchlin presents Day 3 highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 2 RA Highlights
07/11/2020 Durata: 04minProf Christopher Edwards presents Day 2 highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 2 Beyond RA Highlights
07/11/2020 Durata: 07minProf Christopher Edwards presents Day 2highlights of the key abstracts and posters presented at ACR 2020.
-
Insights at ACR 2020: Day 1 RA Highlights
05/11/2020 Durata: 16minProf Leonard Calabrese presents the Day 1 highlights of the key abstracts and posters presented at ACR 2020.